GlassScriptPhysician profile
Karen A Ragaini
NPI 1831176270
$3,069.26
in general payments reported to CMS, 2019-2025
30 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $317 · 2021: $721 · 2022: $600 · 2023: $443 · 2024: $249 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $899 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $898.71 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $647.19 | 2019-2023 | |
| Myovant Sciences INC. | $282.93 | 2021-2022 | |
| Minerva Surgical, INC | $204.01 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $199.57 | 2022-2025 | |
| Therapeuticsmd, INC. | $191.76 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $180.49 | 2023 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $122.35 | 2019-2023 | |
| Pfizer INC. | $117.80 | 2019-2025 | |
| Astellas Pharma US INC | $114.65 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $111.74 | 2020-2021 | |
| Organon LLC | $102.57 | 2021-2023 | Nexplanon |
| Exeltis, USA INC. | $80.71 | 2020-2025 | Slynd |
| Agile Therapeutics, INC. | $66.75 | 2021-2022 | |
| Lupin INC. | $63.48 | 2019-2021 | |
| Boston Scientific Corporation | $62.48 | 2019-2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $52.40 | 2019-2024 | Paragard T 380a |
| Channel Medsystems, INC. | $49.06 | 2022 | |
| Gynesonics, INC. | $48.78 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $48.64 | 2019-2024 | Femring, Intrarosa |
| Medtronic, INC. | $47.19 | 2024-2025 | Interstim, Venaseal |
| Merck Sharp & Dohme LLC | $43.65 | 2019-2021 | |
| Daiichi Sankyo INC. | $41.50 | 2019-2020 | |
| Scynexis, INC. | $29.01 | 2022 | |
| Roche Diagnostics Corporation | $28.72 | 2021 | |
| Avion Pharmaceuticals | $27.10 | 2020-2021 | |
| Meditrina | $25.11 | 2022-2025 | |
| Biogen, INC. | $24.69 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $23.21 | 2024 | Ova1 |
| Exact Sciences Corporation | $18.11 | 2025 | |
| Allergan, INC. | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Ragaini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.